EUVIMEDEUVIMED entdecken
Open Access

Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank

Parag Anilkumar Chevli iD, Saeid Mirzai iD, Richard Kazibwe iD, Jeff Kingsley, Alexis C Wood iD, Joseph Yeboah iD, Leandro Slipczuk iD, Anurag Mehta iD, Harpreet S Bhatia iD, Ambarish Pandey iD, Michael D Shapiro iD

Journal of the American Heart Association · 03.03.2026 · 15 (5)

DOI: 10.1161/jaha.125.042582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.03.2026. Verfasst von Parag Anilkumar Chevli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Wake Forest University School of Medicine Winston-Salem NC USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Ketone Bodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketone bodies (KB) are endogenous energy sources synthesized by the liver in response to metabolic stress. Their associations with atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), and mortality and their potential beneficial or harmful effects have yet to be determined. This study aimed to examine the association between KB and incident cardiovascular outcomes and mortality in a large general population cohort free from ASCVD and HF at baseline.

Methods

This analysis included 90 987 participants (mean age 56.4 ± 8.1 years; 54.7% women) from the UK Biobank without prevalent ASCVD or HF. KB were measured by nuclear magnetic resonance spectroscopy. The primary outcomes were ASCVD, HF, and all‐cause death. Secondary outcomes were myocardial infarction, ischemic stroke, peripheral artery disease, and CVD death. All outcomes were defined based on International Classification of Diseases, Ninth Revision ( ICD‐9 ) and Tenth Revision ( ICD‐10 ) codes. Multivariable‐adjusted Cox proportional hazards models examined the association of total KB with incident cardiovascular outcomes and mortality.

Results

At a median follow‐up of 13.4 years, higher levels of total KB (per 10‐fold increase) were associated with a greater risk of incident ASCVD, HF, and all‐cause mortality (hazard ratio [HR], 1.31 [95% CI, 1.18–1.46], 1.44 [95% CI, 1.24–1.6]7, and 1.51 [95% CI, 1.38–1.66]), respectively. Participants also demonstrated a 37% (95% CI, 11%–69%) increased risk of stroke and 69% (95% CI, 43%–100%) increased risk of CVDdeath. There was no significant association between KB and incident myocardial infarction.

Conclusions

Elevation in endogenous KB in a population free from CVD at baseline is associated with an increased risk of ASCVD, HF, stroke, and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesKetone BodiesHumansFemaleMiddle AgedUnited KingdomMaleIncidenceUK BiobankAgedBiological Specimen BanksRisk FactorsCause of DeathBiomarkersRisk Assessment

Stichwörter der Autor:innen

atherosclerotic cardiovascular diseaseheart failureketone bodiesmortality

Substanzen

Ketone BodiesBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine Wake Forest University School of Medicine Winston-Salem NC USA.
  • Section on Hospital Medicine, Department of Internal Medicine Wake Forest University School of Medicine Winston-Salem NC USA.
  • USDA/ARS Children's Nutrition Research Center Baylor College of Medicine Houston TX USA.
  • Division of Cardiology Montefiore Healthcare Network/Albert Einstein College of Medicine New York NY USA.
  • VCU Health Pauley Heart Center and Division of Cardiology, Department of Internal Medicine Virginia Commonwealth University School of Medicine Richmond VA USA.
  • Division of Cardiovascular Medicine, Department of Medicine University of California San Diego La Jolla CA USA.

ORCID-Profile: Parag Anilkumar Chevli, Saeid Mirzai, Richard Kazibwe, Alexis C Wood, Joseph Yeboah, Leandro Slipczuk, Anurag Mehta, Harpreet S Bhatia, Ambarish Pandey, Michael D Shapiro

Zitieren

APA

Chevli, P. A., Mirzai, S., Kazibwe, R., Kingsley, J., Wood, A. C., Yeboah, J., Slipczuk, L., Mehta, A., Bhatia, H. S., Pandey, A., & Shapiro, M. D. (2026). Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank. Journal of the American Heart Association, 15(5). https://doi.org/10.1161/jaha.125.042582

Vancouver

Chevli PA, Mirzai S, Kazibwe R, Kingsley J, Wood AC, Yeboah J, et al. Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank. Journal of the American Heart Association. 2026;15(5). doi:10.1161/jaha.125.042582

BibTeX
@article{Chevli2026,
  author = {Chevli, Parag Anilkumar and Mirzai, Saeid and Kazibwe, Richard and Kingsley, Jeff and Wood, Alexis C and Yeboah, Joseph and Slipczuk, Leandro and Mehta, Anurag and Bhatia, Harpreet S and Pandey, Ambarish and Shapiro, Michael D},
  title = {Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1161/jaha.125.042582}
}
Kostenlos starten →